Acceptability, safety, and efficacy of oral administration of extracts of black or red maca (Lepidium meyenii) in adult human subjects: A randomized, double-blind, placebo-controlled study

Pharmaceuticals

Volumn 9, Issue 3, 2016, Pages

  Gonzales Arimborgo, Carla ^a,b   Yupanqui, Irma ^b,c   Montero, Elsa ^b,c   Alarcón Yaquetto, Dulce E ^a,b   Zevallos Concha, Alisson ^a,b   Caballero, Lidia ^b,d   Gasco, Manuel ^a,b   Zhao, Jianping ^e   Khan, Ikhlas A ^e   Gonzales, Gustavo F ^a,b  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b Research Circle on Plants with Effects on Health ^*  (Peru)

^c UNIVERSIDAD NACIONAL DANIEL ALCIDES CARRIÓN   (Peru)

^d UNIVERSIDAD NACIONAL DEL ALTIPLANO   (Peru)

^e UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Adverse effects; Black maca; Botanicals; High altitude; Human health; Lepidium meyenii; Nutraceuticals; Placebo; Red maca; Toxicity

Indexed keywords

4 AMINOBUTYRIC ACID; FATTY ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN; LEPIDIUM MEYENII EXTRACT; MACAMIDE DERIVATIVE; PLACEBO; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGED; ALTITUDE; ALTITUDE DISEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ENERGY EXPENDITURE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN EXPERIMENT; MOOD CHANGE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VARIETAS;

EID: 84983261830     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph9030049     Document Type: Article

References (48)

1. Valerio, L.; Gonzales, G.F. Toxicological aspects of the South American herbs cat’s claw (Uncaria tomentosa) and Maca (Lepidium meyenii): A critical sypnosis. Toxicol. Rev. 2005, 24, 11-35. [CrossRef] [PubMed]
2. Gonzales, G.F.; Villaorduña, L.; Gasco, M.; Rubio, J.; Gonzales, C. Maca (Lepidium meyenii Walp), a review of its biological properties. Rev. Peru. Med. Exp. Salud Publica 2014, 31, 100-110. [PubMed]
3. Gonzales, G.F.; Gasco, M.; Malheiros-Pereira, A.; Gonzales-Castañeda, C. Antagonistic effect of Lepidium meyenii (red maca) on prostatic hyperplasia in adult mice. Andrologia 2008, 40, 179-185. [CrossRef] [PubMed]
4. Gonzales, C.; Cárdenas-Valencia, I.; Leiva-Revilla, J.; Anza-Ramirez, C.; Rubio, J.; Gonzales, G.F. Effect of different varieties of Maca (Lepidium meyenii) on bone structure in ovariectomized rats. Forsch. Komplementmed. 2010, 17, 137-143. [CrossRef] [PubMed]
5. Gonzales, G.F.; Gonzales-Castañeda, C.; Gasco, M. A mixture of extracts from Peruvian plants (black maca and yacon) improves sperm count and reduced glycemia in mice with streptozotocin-induced diabetes. Toxicol. Mech. Methods 2013, 23, 509-518. [CrossRef] [PubMed]
6. Rubio, J.; Yucra, S.; Gasco, M.; Gonzales, G.F. Dose-response effect of black maca (Lepidium meyenii) in mice with memory impairment induced by ethanol. Toxicol. Mech. Methods 2011, 21, 628-634. [CrossRef] [PubMed]
7. Ranilla, L.G.; Kwon, Y.I.; Apostolidis, E.; Shetty, K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010, 101, 4676-4689. [CrossRef] [PubMed]
8. Gonzales, G.F.; Gasco, M.; Lozada-Requena, I. Role of maca (Lepidium meyenii) consumption on serum interleukin-6 levels and health status in populations living in the Peruvian Central Andes over 4000 m of altitude. Plant Foods Hum. Nutr. 2013, 68, 347-351. [CrossRef] [PubMed]
9. Jiang, Y.; Wu, S.H.; Shu, X.O.; Xiang, Y.B.; Ji, B.T.; Milne, G.L.; Cai, Q.; Zhang, X.; Gao, Y.T.; Zheng, W. et al. Cruciferous vegetable intake is inversely correlated with circulating levels of proinflammatory markers in women. J. Acad. Nutr. Diet. 2014, 114, 700-709. [CrossRef] [PubMed]
10. Tilg, H. Cruciferous vegetables: Prototypic anti-inflammatory food components. Clin. Phytosci. 2015, 1, 10. [CrossRef]
11. Peñaloza, D.; Arias-Stella, J. The heart and pulmonary circulation at high altitudes: Healthy highlanders and chronic mountain sickness. Circulation 2007, 115, 1132-1146. [CrossRef]
12. Gonzales, G.F. Maca: Del alimento perdido de los Incas al milagro de los Andes: Estudio de seguridad alimentaria y nutricional. Segurança Aliment. Nutr. Camp. 2010, 17, 16-36.
13. Gonzales, G.F.; Córdova, A.; Vega, K.; Chung, A.; Villena, A.; Góñez, C.; Castillo, S. Effect of Lepidium meyenii (Maca) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia 2002, 34, 367-372. [CrossRef] [PubMed]
14. Stone, M.; Ibarra, A.; Roller, M.; Zangara, A.; Stevenson, E. A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. J. Ethnopharmacol. 2009, 126, 574-576. [CrossRef] [PubMed]
15. Stojanovska, L.; Law, C.; Lai, B.; Chung, T.; Nelson, K.; Day, S.; Apostolopoulos, V.; Haines, C. Maca reduces blood pressure and depression, in a pilot study in postmenopausal women. Climacteric 2015, 18, 69-78. [CrossRef] [PubMed]
16. Gonzales, G.F.; Córdova, A.; Vega, K.; Chung, A.; Villena, A.; Góñez, C. Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J. Endocrinol. 2003, 176, 163-168. [CrossRef] [PubMed]
17. Zenico, T.; Cicero, A.F.; Valmorri, L.; Metrcuriali, M.; Bercovich, E. Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performance in patients with mild erectile dysfunction: A randomised, double-blind clinical trial. Andrologia 2009, 41, 95-99. [CrossRef] [PubMed]
18. Almukadi, H.; Wu, H.; Böhlke, M.; Kelley, C.J.; Maher, T.J.; Pino-Figueroa, A. The macamide N-3-methoxybenzyl-linoleamide is a time-dependent fatty acid amide hydrolase (FAAH) inhibitor. Mol. Neurobiol. 2013, 48, 333-339. [CrossRef] [PubMed]
19. Hajdu, Z.; Nicolussi, S.; Rau, M.; Lorántfy, L.; Forgo, P.; Hohmann, J.; Csupor, D.; Gertsch, J. Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii. J. Nat. Prod. 2014, 77, 1663-1669. [CrossRef] [PubMed]
20. Bambico, F.R.; Gobbi, G. The cannabinoid CB1 receptor and the endocannabinoid anandamide: Possible antidepressant targets. Expert Opin. Ther. Targets 2008, 12, 1347-1366. [CrossRef] [PubMed]
21. Shiah, I.-S.; Yatmah, L.N. GABA function in mood disorders: An update and critical review. Life Sci. 1998, 63, 1289-1303. [CrossRef]
22. Wozniak, J.R.; Fuglestad, A.J.; Eckerle, J.K.; Fink, B.A.; Hoecker, H.L.; Boys, C.J.; Radke, J.P.; Kroupina, M.G.; Miller, N.C.; Brearley, A.M. et al. Choline supplementation in children with fetal alcohol spectrum disorders: A randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 2015, 102, 1113-1125. [CrossRef] [PubMed]
23. Naber, M.; Hommel, B.; Colzato, L.S. Improved human visuomotor performance and pupil constriction after choline supplementation in a placebo-controlled double-blind study. Sci. Rep. 2015, 5, 13188. [CrossRef] [PubMed]
24. Knott, V.; de la Salle, S.; Choueiry, J.; Impey, D.; Smith, D.; Smith, M.; Beaudry, E.; Saghir, S.; Ilivitsky, V.; Labelle, A. Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers. Pharmacol. Biochem. Behav. 2015, 131, 119-129. [CrossRef] [PubMed]
25. Schenkel, L.C.; Sivanesan, S.; Zhang, J.; Wuyts, B.; Taylor, A.; Verbrugghe, A.; Bakovic, M. Choline supplementation restores substrate balance and alleviates complications of Pcyt2 deficiency. J. Nutr. Biochem. 2015, 26, 1221-1234. [CrossRef] [PubMed]
26. McCall, N.; Mahadevia, D.; Corriveau, J.A.; Glenn, M.J. Adult emotionality and neural plasticity as a function of adolescent nutrient supplementation in male rats. Pharmacol. Biochem. Behav. 2015, 132, 125-135. [CrossRef] [PubMed]
27. Sidhu, N.; Davies, S.; Nadarajah, A.; Rivera, J.; Whittington, R.; Mercier, R.J.; Virag, L.; Wang, S.; Flood, P. Oral choline supplementation for postoperative pain. Br. J. Anaesth. 2013, 111, 249-255. [CrossRef] [PubMed]
28. Valentová, K.; Stejskal, D.; Bartek, J.; Dvorácková, S.; Kren, V.; Ulrichová, J.; Simánek, V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: In vivo safety assessment. Food Chem. Toxicol. 2008, 46, 1006-1013. [CrossRef] [PubMed]
29. Vecera, R.; Orolin, J.; Skottová, N.; Kazdová, L.; Oliyarnik, O.; Ulrichová, J.; Simánek, V. The influence of maca (Lepidium meyenii) on antioxidant status, lipid and glucose metabolism in rat. Plant Foods Hum. Nutr. 2007, 62, 59-63. [CrossRef] [PubMed]
30. Woolcott, O.O.; Ader, M.; Bergman, R.N. Glucose homeostasis during short-term and prolonged exposure to high altitudes. Endocr. Rev. 2015, 36, 149-173. [CrossRef] [PubMed]
31. Meissner, H.O.; Reich-Bilinska, H.; Mscisz, A.; Kedzia, B. Therapeutic effects of pregelatinized maca (Lepidium peruvianum Chacon) used as non-hormonal alternative to HRT in perimenopausal women-Clinical pilot study. Int. J. Biomed. Sci. 2006, 2, 143-159. [PubMed]
32. Kaptchuk, T.J. The placebo effect in alternative medicine: Can the performance of a healing ritual have clinical significance? Ann. Intern. Med. 2002, 136, 817-825. [CrossRef] [PubMed]
33. Kaptchuk, T.J.; Miller, F.G. Placebo effects in medicine. N. Engl. J. Med. 2015, 373, 8-9. [CrossRef] [PubMed]
34. Hall, K.T.; Loscalzo, J.; Kaptchuk, T.J. Genetics and the placebo effect: The placebome. Trends Mol. Med. 2015, 21, 285-294. [CrossRef] [PubMed]
35. Benedetti, F.; Durando, J.; Vighetti, S. Nocebo and placebo modulation of hypobaric hypoxia headeche involves the cyclooxygenase-prostaglandins pathway. Pain 2014, 155, 921-928. [CrossRef] [PubMed]
36. Andreeva, V.A.; Martin, C.; Issanchou, S.; Hercberg, S.; Kesse-Guyot, E.; Méjean, C. Sociodemographic profiles regarding bitter food consumption: Cross-sectional evidence from a general French population. Appetite 2013, 67, 53-60. [CrossRef] [PubMed]
37. Wooding, S.; Gunn, H.; Ramos, P.; Thalmann, S.; Xing, C.; Meyerhof, W. Genetics and bitter responses to goitrin, a plant toxin found in vegetables. Chem. Senses 2010, 35, 685-692. [CrossRef] [PubMed]
38. Ippushi, K.; Ueda, H.; Takeuchi, A. Milk prevents the degradation of daikon (Raphanus sativus L.) isothyocyanate and enhances its absorption in rats. Food Chem. 2014, 161, 176-180. [CrossRef] [PubMed]
39. Sansom, C.E.; Jones, V.S.; Joyce, N.I.; Smallfield, B.M.; Perry, N.B.; van Klink, J.W. Flavor, glucosinolates, and isothiocyanates of nau (Cooks scurvy grass, Lepidium oleraceum) and other rare New Zealand Lepidium species. J. Agric. Food Chem. 2015, 63, 1833-1838. [CrossRef] [PubMed]
40. Posadzki, P.; Watson, L.K.; Ernst, E. Adverse effects of herbal medicines: An overview of systematic reviews. Clin. Med. (Lond.) 2013, 13, 7-12. [CrossRef] [PubMed]
41. Gasco, M.; Aguilar, J.; Gonzales, G.F. Effect of chronic treatment with three varieties of Lepidium meyenii (Maca) on reproductive parameters and DNA quantification in adult male rats. Andrologia 2007, 39, 151-158. [CrossRef] [PubMed]
42. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22, 659-661. [CrossRef] [PubMed]
43. FDA. IND [Investigational New Drug Application] PHASES of an Investigation. Title 21, Vol 5, Code of Federal Regulations 312.21; Government Printing Office: Washington, DC, USA, 1 April 2012.
44. Zhao, J.; Avula, B.; Chan, M.; Clément, C.; Kreuzer, M.; Khan, I.A. Metabolomic differentiation of maca (Lepidium meyenii) accessions cultivated under different conditions using NMR and chemometric analysis. Planta Med. 2012, 78, 90-101. [CrossRef] [PubMed]
45. Vilagut, G.; Ferrer, M.; Rajmil, L.; Rebollo, P.; Permanyer-Miralda, G.; Quintana, J.M.; Santed, R.; Valderas, J.M.; Ribera, A.; Domingo-Salvany, A. et al. The Spanish version of the Short Form 36 Health Survey: A decade of experience and new developments. Gac. Sanit. 2005, 19, 135-150. [CrossRef] [PubMed]
46. León-Velarde, F.; Maggiorini, M.; Reeves, J.T.; Aldashev, A.; Asmus, I.; Bernardi, L.; Ge, R.L.; Hackett, P.; Kobayashi, T.; Moore, L.G. et al. Consensus statement on chronic and subacute high altitude diseases. High Alt. Med. Biol. 2005, 6, 147-157. [CrossRef] [PubMed]
47. McGough, C.; Peacock, N.; Hackett, C.; Baldwin, C.; Norman, A.; Frost, G.; Blake, P.; Tait, D.; Khoo, V.; Harrington, K. et al. Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: A double-blind controlled study. Clin. Nutr. 2006, 25, 906-912. [CrossRef] [PubMed]
48. Vacha-Haase, T.; Thompson, B. How to estimate and interpret various effect sizes. J. Couns. Psychol. 2004, 51, 473-481. [CrossRef]